Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, May 31 '25)

Image
By G.M.


 

    Am J Respir Crit Care Med

  1. KRISHNAN JA, Cao B, Chotirmall SH, Ely EW, et al
    Using the 2024 NASEM Definition of Long COVID: Implications for Pulmonary and Critical Care Medicine.
    Am J Respir Crit Care Med. 2025.
    PubMed        


    BMJ

  2. IBRAHIM S, Siemieniuk RAC, Oliveros MJ, Islam N, et al
    Drug treatments for mild or moderate covid-19: systematic review and network meta-analysis.
    BMJ. 2025;389:e081165.
    PubMed         Abstract available

  3. BOSAEED M, Alraddadi BM
    Navigating the complexities of mild and moderate covid-19 treatment.
    BMJ. 2025;389:r1016.
    PubMed        

  4. TANNE JH
    US no longer recommends covid-19 vaccinations for pregnant women or children.
    BMJ. 2025;389:r1104.
    PubMed        

  5. O'DOWD A, Iacobucci G
    Covid-19: Early call to test healthcare staff was ignored, inquiry hears.
    BMJ. 2025;389:r1092.
    PubMed        


    Clin Infect Dis

  6. WOLFE CR, Cohen J, Mahoney K, Holmes A, et al
    Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY).
    Clin Infect Dis. 2025 May 24:ciaf265. doi: 10.1093.
    PubMed         Abstract available


    Emerg Infect Dis

  7. ROSAS IO, Benitez A, McKinnell JA, Shah R, et al
    Long-Term Clinical Outcomes of Adults Hospitalized for COVID-19 Pneumonia.
    Emerg Infect Dis. 2025;31:1158-1168.
    PubMed         Abstract available


    Int J Infect Dis

  8. DEBIE Y, Verbruggen L, Peeters M, van Dam PA, et al
    mRNA COVID-19 vaccines induce superior IgA titers in cancer patients compared to viral vector vaccines: Implications for immunization strategies.
    Int J Infect Dis. 2025 May 23:107939. doi: 10.1016/j.ijid.2025.107939.
    PubMed         Abstract available


    J Infect

  9. RIEDMANN U, Chalupka A, Richter L, Werber D, et al
    Corrigendum to "Underlying health biases in previously-infected SARS-CoV-2 vaccination recipients: A cohort study" [J Infect 90 (2025) 106497].
    J Infect. 2025;91:106522.
    PubMed        


    J Med Virol

  10. PIAZZESE C, Williams S, Brentall A, Kele B, et al
    Analysis of Variants' Dynamic Using the CLIMB Database in COVID-19 Patients Admitted to Hospitals of Barts Health NHS Trust.
    J Med Virol. 2025;97:e70402.
    PubMed         Abstract available

  11. LIU K, Rao J, Hu X, Sun H, et al
    Maternal Vaccination and Protective Immunity Against SARS-CoV-2 Infection in Pups.
    J Med Virol. 2025;97:e70418.
    PubMed         Abstract available

  12. PENG W, Wei X, Wu Y, Shi C, et al
    Dynamic Molecular Changes in Brain, Lung, and Heart of Hamsters Infected With SARS-CoV-2: Insights From a Severe and Recovery Phase Model.
    J Med Virol. 2025;97:e70410.
    PubMed         Abstract available

  13. ALIYARI SR, Shanaa J, Yu D, Yamamoto M, et al
    Suppression of Monkeypox Virus by Downregulation of Fatty Acid Synthase and Upregulation of Cholesterol-25 Hydroxylase.
    J Med Virol. 2025;97:e70403.
    PubMed         Abstract available


    J Virol

  14. WANG Y, Tong W, Qin W, Yang X, et al
    Midnolin inhibits coronavirus proliferation by degrading viral proteins.
    J Virol. 2025 May 29:e0036625. doi: 10.1128/jvi.00366.
    PubMed         Abstract available

  15. GUO L, Duan X, Li J, Hao Z, et al
    YIPF5 is an essential host factor for porcine epidemic diarrhea virus double-membrane vesicle formation.
    J Virol. 2025 May 27:e0032025. doi: 10.1128/jvi.00320.
    PubMed         Abstract available

  16. POGANY J, Inaba J-i, Liu Y, Nagy PD, et al
    Screening bacterial effectors and human virus proteins in yeast to identify host factors driving tombusvirus RNA recombination: a role for autophagy and membrane phospholipid content.
    J Virol. 2025 May 27:e0166124. doi: 10.1128/jvi.01661.
    PubMed         Abstract available


    Lancet Infect Dis

  17. FOLEGATTI PM, Pepin S, Tabar C, Fries K, et al
    Comparative assessment of immunogenicity and safety of recombinant influenza vaccine in children, adolescents, and adults: results from a phase 3, immunobridging, open-label, non-randomised study.
    Lancet Infect Dis. 2025 May 21:S1473-3099(25)00153.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  18. LAMBROU AS, South E, Midgley CM, Harrington C, et al
    Update on the Epidemiology of Middle East Respiratory Syndrome Coronavirus - Worldwide, 2017-2023.
    MMWR Morb Mortal Wkly Rep. 2025;74:313-320.
    PubMed         Abstract available


    Nature

  19. HILL R, Yin Y, Stein C, Wang X, et al
    The pivot penalty in research.
    Nature. 2025 May 28. doi: 10.1038/s41586-025-09048.
    PubMed         Abstract available

  20. ZHAO Y, Zheng B, Saunois M, Ciais P, et al
    Air pollution modulates trends and variability of the global methane budget.
    Nature. 2025 May 28. doi: 10.1038/s41586-025-09004.
    PubMed         Abstract available


    Radiologia (Engl Ed)

  21. PEREZ LAENCINA M, Plasencia Martinez JM, Sanchez Canales M, Jimenez Pulido C, et al
    A commercial AI tool untrained for COVID-19 demonstrates slight improvement in the interpretation of COVID-19 pneumonia x-rays, especially among inexperienced readers.
    Radiologia (Engl Ed). 2025;67:273-286.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

Stability of #influenza viruses in the #milk of #cows and #sheep

By G.M.
Abstract In late 2023, H5N1 high pathogenicity avian influenza (HPAIV) started circulating in dairy cattle in the USA . High viral titres were detected in milk from infected cows , raising concerns about onwards human infections . Although pasteurisation was shown to effectively inactivate influenza viruses in milk, unpasteurised milk still poses a risk of infection, both from occupational exposure in dairies and from the consumption of raw milk. We therefore assessed how long influenza viruses could remain infectious for in milk without heat inactivation. We examined the stability of a panel of influenza viruses in milk , including a contemporary H5N1 HPAIV and a variety of other influenza A and D viruses. We incubated viruses in cows' milk under laboratory conditions : at room temperature to simulate exposure in dairies and at 4°C to simulate exposure to refrigerated raw milk. Following an isolated report of H5N1 viral RNA being detected in milk from a sheep in the UK , we also c...
Post a Comment
Read more »

#Evidence of #Viremia in Dairy #Cows Naturally Infected with #Influenza A {#H5N1} Virus, #California, #USA

By G.M.
Abstract We confirmed influenza A virus (IAV) by PCR in serum from 18 cows on 3 affected dairy farms in California, USA . Our findings indicate the presence of viremia and might help explain IAV transmission dynamics and shedding patterns in cows. An understanding of those dynamics could enable development of IAV mitigation strategies. Source: US Centers for Disease Control and Prevention,  https://wwwnc.cdc.gov/eid/article/31/7/25-0134_article ____
Post a Comment
Read more »